[HTML][HTML] Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
R Mattioli, A Ilari, B Colotti, L Mosca, F Fazi… - Molecular Aspects of …, 2023 - Elsevier
Anthracyclines have been important and effective treatments against a number of cancers
since their discovery. However, their use in therapy has been complicated by severe side …
since their discovery. However, their use in therapy has been complicated by severe side …
MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis
To protect tissues and the organism from disease, potentially harmful cells are removed
through programmed cell death processes, including apoptosis and necroptosis. These …
through programmed cell death processes, including apoptosis and necroptosis. These …
miR‐193: a new weapon against cancer
M Khordadmehr, R Shahbazi… - Journal of cellular …, 2019 - Wiley Online Library
Abstract microRNAs (miRNAs) are known as a large group of short noncoding RNAs, which
structurally consist of 19–22 nucleotides in length and functionally act as one of the main …
structurally consist of 19–22 nucleotides in length and functionally act as one of the main …
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
Background Chemotherapy is one of the most common treatment options for breast cancer
(BC) patients. However, about half of the BC patients are chemotherapeutic resistant …
(BC) patients. However, about half of the BC patients are chemotherapeutic resistant …
Noncoding RNAs: the shot callers in tumor immune escape
L Liu, Q Wang, Z Qiu, Y Kang, J Liu, S Ning… - Signal transduction and …, 2020 - nature.com
Immunotherapy, designed to exploit the functions of the host immune system against tumors,
has shown considerable potential against several malignancies. However, the utility of …
has shown considerable potential against several malignancies. However, the utility of …
MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
Abstract Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is responsible for
metabolism of an endogenous inhibitor of nitric oxide synthase (NOS), asymmetric …
metabolism of an endogenous inhibitor of nitric oxide synthase (NOS), asymmetric …
Contribution of miRNAs in the Pathogenesis of Breast Cancer
S Ghafouri-Fard, A Khanbabapour Sasi, A Abak… - Frontiers in …, 2021 - frontiersin.org
Breast cancer is the most frequently diagnosed cancer among females. Gene expression
profiling methods have shown the deregulation of several genes in breast cancer samples …
profiling methods have shown the deregulation of several genes in breast cancer samples …
[HTML][HTML] Autophagy-mediating microRNAs in cancer chemoresistance
Y Jing, W Liang, J Liu, L Zhang, J Wei, J Yang… - Cell biology and …, 2020 - Springer
Chemoresistance is a complex phenomenon responsible for failure in response to
chemotherapy agents and more than 90% of deaths in cancer patients. MicroRNAs …
chemotherapy agents and more than 90% of deaths in cancer patients. MicroRNAs …
MicroRNAs as a clue to overcome breast cancer treatment resistance
I Garrido-Cano, B Pattanayak, A Adam-Artigues… - Cancer and Metastasis …, 2022 - Springer
Breast cancer is the most frequent cancer in women worldwide. Despite the improvement in
diagnosis and treatments, the rates of cancer relapse and resistance to therapies remain …
diagnosis and treatments, the rates of cancer relapse and resistance to therapies remain …
The role of microRNAs on doxorubicin drug resistance in breast cancer
K Jamialahmadi, F Zahedipour… - Journal of Pharmacy and …, 2021 - academic.oup.com
Objectives Resistance to chemotherapeutic drugs is a serious challenge for effective therapy
of cancers. Doxorubicin is a drug which is typically used for breast cancer treatment. Several …
of cancers. Doxorubicin is a drug which is typically used for breast cancer treatment. Several …